Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 37 min ago
Peer-reviewedCC BY-NC-NDTranslational cancer research

Personalized prediction of sequential therapeutic responses in HR+/HER2-low breast cancer using patient-derived organoids

  • Wei Zhao1
  • Zhongni Wu1
  • Chengpan Li2
  • Hongbo Zhang3
  • Dabing Huang1
  • Lijuan Wang3
  • Xiaodan Zhang4
  • Juanjuan Zhang5
  • Xinyu Ma2
  • Yifan Wen6
  • Joseph Benjamin Holman2
  • Xudong Yuan7
4 more authors
  • Tingting Wang8
  • Wei Wang1
  • Weiping Ding1
  • Yueyin Pan1
8 affiliations
  1. 1Department of Medical Oncology , The First Affiliated Hospital of USTC , Division of Life Sciences and Medicine , University of Science and Technology of China , Hefei , ;
  2. 2School of Information Science and Technology , University of Science and Technology of China , Hefei , ;
  3. 3Department of Radiation Oncology , The First Affiliated Hospital of USTC , Division of Life Sciences and Medicine , University of Science and Technology of China , Hefei , ;
  4. 4Department of Pharmacy , The First Affiliated Hospital of USTC , Division of Life Sciences and Medicine , University of Science and Technology of China , Hefei , ;
  5. 5Department of Radiation Oncology , Linquan County People’s Hospital , Fuyang , ;
  6. 6College of Integrated Chinese and Western Medicine , Anhui University of Chinese Medicine , Hefei , ;
  7. 7Department of Radiation Oncology , Bengbu Medical University , Bengbu , ;
  8. 8Department of Medical Oncology , Provincial Hospital Affiliated to Anhui Medical University , Hefei ,
Read full textPDFCite

Related

  1. Optimizing the Therapeutic Index: Sequential Intraarterial–Intravenous PRRT with Personalized Volumetric-Adjusted Dosing
    Lisa Bodei, Etay Ziv, Audrey Mauguen +8
    Journal of Nuclear MedicinePeer-reviewedLicence not statedFull textEpidemiology & public healthPMC
  2. Personalized Therapeutic Strategies in Glioblastoma: Bridging Molecular Markers and In Vivo Observations for Targeted Treatment
    Joaquin Fiallo Arroyo, Jose E. Leon-Rojas
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. From digital reminders to artificial intelligence–enabled understanding: can personalized treatment predictions improve therapeutic adherence?
    Valentin Goutaudier, Jean-Sébastien Hulot
    European Heart Journal. Cardiovascular PharmacotherapyPeer-reviewedCC BY 4.0Full text1 citedCardiovascular medicinePMC
  4. GEM-GPT Enables Personalized Cell Type-Resolved Therapeutic Design for Systems Pharmacology
    S. Zhang, R. Ohlan, M. Mottaqi +1
    bioRxivPreprintCC BY-NCFull textPharmacology & toxicologybioRxiv
  5. Personalized genomic landscape of prostate cancer in African American men reveals novel drivers and therapeutic opportunities
    Shanta Murthy, Katie Fago, James Knight +5
    PLOS OnePeer-reviewedCC BY 4.0Full textGenetics & genomicsOncologyPLOS

Cite

BibTeXRIS
BibTeX
@article{zhao2026personalized,
  title = {{Personalized prediction of sequential therapeutic responses in HR+/HER2-low breast cancer using patient-derived organoids}},
  author = {Wei Zhao and Zhongni Wu and Chengpan Li and Hongbo Zhang and Dabing Huang and Lijuan Wang and Xiaodan Zhang and Juanjuan Zhang and Xinyu Ma and Yifan Wen and Joseph Benjamin Holman and Xudong Yuan and Tingting Wang and Wei Wang and Weiping Ding and Yueyin Pan},
  journal = {Translational cancer research},
  year = {2026},
  month = aug,
  url = {https://europepmc.org/article/PMC/PMC13657817},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Personalized prediction of sequential therapeutic responses in HR+/HER2-low breast cancer using patient-derived organoids
AU  - Wei Zhao
AU  - Zhongni Wu
AU  - Chengpan Li
AU  - Hongbo Zhang
AU  - Dabing Huang
AU  - Lijuan Wang
AU  - Xiaodan Zhang
AU  - Juanjuan Zhang
AU  - Xinyu Ma
AU  - Yifan Wen
AU  - Joseph Benjamin Holman
AU  - Xudong Yuan
AU  - Tingting Wang
AU  - Wei Wang
AU  - Weiping Ding
AU  - Yueyin Pan
PY  - 2026
DA  - 2026/08/26
JO  - Translational cancer research
UR  - https://europepmc.org/article/PMC/PMC13657817
SN  - 2218-676X
ER  -